BJU international
-
Randomized Controlled Trial Multicenter Study Clinical Trial
Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial.
To further assess, in a phase 3 study, treatment with duloxetine for women with stress urinary incontinence (SUI) in other geographical regions, including Argentina, Australia, Brazil, Finland, Poland, South Africa and Spain, as previous trials in North America and Europe provided evidence for the safety and efficacy of duloxetine as a pharmacological treatment for SUI in women. ⋯ These results show improvements in incontinence and quality of life with duloxetine 40 mg twice daily for 12 weeks that are in keeping with those reported in two other recently completed phase 3 trials in Europe and North America.
-
Randomized Controlled Trial Multicenter Study Clinical Trial
The effect of drotaverine hydrochloride in acute colicky pain caused by renal and ureteric stones.
To assess the spasmolytic effect of drotaverine hydrochloride in colicky pain caused by renal and ureteric stones. ⋯ Intravenous drotaverine provides effective pain relief in more than two-thirds of patients with renal colic, with no serious side-effects.
-
To determine how prepared operating departments are to manage latex-allergic patients, and particularly urologists, because the highest incidence of latex allergy occurs in patients with spina bifida who undergo frequent urological procedures. ⋯ This survey shows that many hospitals are inadequately prepared to manage latex-allergic patients, because they lack anaesthetic and urological latex-free equipment.